Sekou-Toure Regional Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00536848
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Sekou-Toure Regional Hosipital, Mwanza, Tanzania

Active Ingredients

Drugs in Phase 3 Trials (3)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (2 trials)

metronidazole (flagyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 3)

Vaginal Diseases (Phase 3)

Vaginosis, Bacterial (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3